Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
UACC-812
HER2amp
Luminal
Doxorubicin
TOP2
TOP
10151.034
uM
0.04740
0.10608
-1.0000 -1.0000 1.3638 1.0938
0.9616
0.3226
UACC-812
HER2amp
Luminal
CPT-11
TOP1
TOP
10151.034
uM
2.18960
2.47240
-0.6914 -0.4143 4.9682 0.3383
0.9554
0.3226
UACC-812
HER2amp
Luminal
CGC-11047
Polyamine analogue
10151.034
uM
2.57870
64.17660
-1.0000 -1.0000 0.3418 0.7599
0.7768
0.3226
BT-549
TNBC
Basal B
GSK1070916
AURK
AURK
10261.001
uM
3.66530
7.32490
-0.9301 -1.0000 1.5867 0.2924
0.9804
2.3472
BT-549
TNBC
Basal B
GSK461364
PLK1
PLK
10261.001
uM
0.06157
0.15170
-0.4222 -0.4109 0.6651 0.5699
0.9713
2.3472
BT-549
TNBC
Basal B
GSK923295
CENPE
Kinesin
10261.001
uM
0.05714
0.05080
0.2077 0.2224 4.9999 0.3810
0.9940
2.3472
BT-549
TNBC
Basal B
Docetaxel
TUBB
TUBB
10261.002
uM
0.00660
0.00553
0.1803 0.1400 1.8504 0.4965
0.9808
2.1983
BT-549
TNBC
Basal B
Taxol
TUBB
TUBB
10261.002
uM
0.01012
0.00927
0.0166 0.1038 2.6731 0.5610
0.9897
2.1983
BT-549
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
10261.011
uM
0.01194
0.01438
-0.1730 -0.1227 1.1802 0.7950
0.9945
2.4327
BT-549
TNBC
Basal B
Carboplatin
DNA cross-linker
DNA cross-linker
10261.011
uM
20.3880
32.63670
-0.4246 -0.4607 1.3880 0.4313
0.9983
2.4327
BT-549
TNBC
Basal B
Oxaliplatin
DNA cross-linker
DNA cross-linker
10261.011
uM
3.26910
29.80390
-0.7067 -1.0000 0.4971 0.5294
0.9547
2.4327
BT-549
TNBC
Basal B
Geldanamycin
HSP90
HSP90
10261.024
uM
0.00607
0.00648
-0.1576 -0.1944 5.0000 0.8906
0.9943
2.1838
BT-549
TNBC
Basal B
Trametinib
MEK
MAPK
10261.024
uM
inf
0.07036
0.5537 0.5551 0.7972 0.1822
0.9709
2.1838
BT-549
TNBC
Basal B
Gefitinib
EGFR
ErbB
10261.024
uM
inf
inf
0.2887 0.2887 0.0000 0.2246
0.0877
2.1838
BT-549
TNBC
Basal B
Cetuximab
EGFR
ErbB
10261.026
uM
inf
inf
0.9943 0.9943 0.0000 -0.0202
-1.1867
2.4866
BT-549
TNBC
Basal B
Trastuzumab
HER2
ErbB
10261.026
uM
inf
7.81790
0.8340 0.5838 4.9972 -0.0048
0.8731
2.4866
BT-549
TNBC
Basal B
CGC-11047
Polyamine analogue
10261.026
uM
64.76250
644.36690
-0.7483 -1.0000 0.4782 0.4717
0.8595
2.4866
BT-549
TNBC
Basal B
17-AAG
HSP90
HSP90
10261.037
uM
0.02633
0.02899
-0.7748 -0.3082 5.0000 0.7926
0.9233
2.1973
BT-549
TNBC
Basal B
CPT-11
TOP1
TOP
10261.121
uM
4.34150
11.72620
-0.6572 -0.8745 1.0178 0.3079
0.9985
2.2540
BT-549
TNBC
Basal B
Doxorubicin
TOP2
TOP
10261.121
uM
0.12617
0.30282
-0.8923 -0.7083 1.0077 0.7467
0.9653
2.2540
BT-549
TNBC
Basal B
Topotecan
TOP1
TOP
10261.121
uM
0.02045
0.03116
-0.3874 -0.4135 1.4319 0.8920
0.9807
2.2540
BT-549
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
10261.131
uM
-inf
0.00002
-0.3245 -0.3912 0.1000 1.0766
0.7849
2.3992
BT-549
TNBC
Basal B
5-FU
TYMS
TYMS
10261.131
uM
215.57540
290.46960
-0.0136 -0.0848 0.5253 0.3560
0.9881
2.3992
BT-549
TNBC
Basal B
Cisplatin
DNA cross-linker
DNA cross-linker
10261.131
uM
1.98770
3.79980
-0.5492 -0.5789 1.1869 0.5255
0.9939
2.3992
HCC1937
TNBC
Basal A
GSK923295
CENPE
Kinesin
10262.001
uM
0.02489
0.02384
-0.1295 0.0319 1.5210 0.5180
0.9664
0.6105